<DOC>
	<DOCNO>NCT02436798</DOCNO>
	<brief_summary>5-HT3 antagonist ( ondansetron ) highly effective medication treatment nausea vomit . However , medication also associate potentially severe life-threatening cardiac adverse drug reaction ( ADRs ) , particularly QT prolongation . Data regard cardiac safety inter-individual variability cardiac effect ondansetron use vulnerable population child pregnant woman limit . The result study enable better-informed therapeutic decision-making regard use ondansetron child pregnant woman , overall goal improve safety commonly use antiemetic medication . Furthermore , predictive pharmacogenetic marker severe 5-HT3 antagonist toxicity could use identify patient risk cardiac toxicity drug administer .</brief_summary>
	<brief_title>5-HT3 Antagonists ( Antiemetics ) Cardiac Safety</brief_title>
	<detailed_description>The specific objective : 1 . Determine compare cardiac safety profile ondansetron child , use prevention management post-operative nausea vomit chemotherapy induce nausea vomiting . Identify clinical factor include pre-existing cardiac condition physiological condition predispose ventricular arrhythmia , concomitant cardiotoxic chemotherapy concomitant volatile anaesthetic agent investigate impact cardiac adverse effect ondansetron . 2 . Determine compare cardiac safety profile ondansetron use pregnant woman woman reproductive age treatment hyperemesis gravidarum post-operative nausea vomit . Identify clinical factor include pre-existing cardiac condition physiological condition , predispose ventricular arrhythmia may support implementation risk mitigation action . 3 . Identify genetic variant associate 5-HT3 antagonist-induced prolongation QT interval .</detailed_description>
	<mesh_term>Antiemetics</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Serotonin 5-HT3 Receptor Antagonists</mesh_term>
	<criteria>1 . Children 6 month 18 year age treat ondansetron prevention management postoperative nausea vomit chemotherapyinduced nausea vomiting . 2 . Pregnant woman woman reproductive age ( 1845 year age ) treat ondansetron hyperemesis gravidarum postoperative nausea vomit . 1 . Patients congenital long QT syndrome . 2 . Subjects speak understand English .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>QT prolongation</keyword>
	<keyword>Genomic biomarkers</keyword>
</DOC>